AZ admitted that the vaccine developed with the University of Oxford to protect against COVID-19 may cause Thrombosis with ...

India's apex body on immunisation NTAGI has recommended administering the second dose of Covid-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said on Sunday.

Presently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National COVID-19 Vaccination Strategy. The recommendation for Covishield is yet to be implemented ...

(Reuters) - The Indian drug regulator's subject expert committee on Wednesday recommended full approval for Covishield and Covaxin, the two COVID-19 vaccines that have dominated the country's ...

Recent revelations regarding a potential rare side effect of AstraZeneca's COVID-19 vaccine, Covishield, have sparked concerns among the public. A legal submission by AstraZeneca admitted that their ...

Covishield and Covaxin are the two vaccines used in the majority of the Indian population. The four permutations for a booster dose evaluated in this study are primary immunization with Covishield ...

British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported. Covishield can cause, in rare cases, a condition that leads to blood ...

The second dose of Covid-19 vaccine Covishield can be administered between eight to 16 weeks after the first shot, India's apex body on immunisation NTAGI has recommended, reported PTI. Quoting ...

According to a study conducted by the Indian Society of Nephrology (ISN), at any given point, one in every 10 adults in India suffers from Chronic Kidney Disease (CKD). (File) India’s apex body on ...

NEW DELHI: A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, according to a new study conducted in India and ...

A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, according to a new study conducted in India and published in The ...